Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium

British Journal of Nutrition

Volumn 101, Issue 2, 2009, Pages 182-189

  Jariwalla, Raxit J ^a,b   Gangapurkar, Bhakti ^b   Nakamura, Daniel ^c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Dr Rath Research Institute   (United States)

^c NONE

Author keywords

Cellular apoptosis; L Selenomethionine; Methyl L selenocysteine; Organic selenium derivatives; Tumour derived cells

Indexed keywords

METHYLSELENOCYSTEINE; SELENIUM DERIVATIVE; SELENOMETHIONINE; TRACE ELEMENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRUCTURE; CELL TYPE; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; EPITHELIUM CELL; EPITHELIUM TUMOR; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; MELANOMA CELL; NEUROEPITHELIUM; SENSITIVITY ANALYSIS;

ADENOCARCINOMA; ADOLESCENT; ADULT; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; CYSTEINE; EPITHELIAL CELLS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; ORGANOSELENIUM COMPOUNDS; SELENIUM COMPOUNDS; SELENOMETHIONINE; SKIN NEOPLASMS;

EID: 67649424362     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508998305     Document Type: Article

References (28)

1. Fleming J, Ghose A & Harrison PR (2001) Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 40, 42-49.
2. Ip C, Dong Y & Ganther HE (2002) New concepts in selenium chemoprevention. Cancer Metastasis Rev 21, 281-289.
3. Medina D, Thompson H, Ganther H & Ip C (2001) Se-methylselenocysteine: A new compound for chemoprevention of breast cancer. Nutr Cancer 40, 12-17.
4. Ujiie S, Itoh Y & Kikuchi H (1998) Serum selenium contents and the risk of cancer. Gan To Kagaku Ryoho 25, 1891-1897.
5. Blot WJ, Li JY, Taylor PR, et al. (1993) Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in general population. J Natl Cancer Inst 85, 1483-1492.
6. Clark LC, Combs GF Jr, Turnbull BW, et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963.
7. Ip C, el-Bayoumy K, Upadhaya P, Ganther H, Vadhanavikit S & Thompson H (1994) Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis 15, 187-192.
8. Lu J, Pei H, Ip C, Lisk DJ, Ganther H & Thompson HJ (1996) Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis 17, 1903-1907.
9. Gail MH, You WC & Chang YS (1998) Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shangdong, China: Design issues and initial data. Control Clin Trials 19 352-369.
10. Kaeck M, Lu J, Strange R, Ip C, Ganther HE & Thompson HJ (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol 53, 921-926.
11. Vadgama JV, Wu Y, Shen D, Hsia S & Block J (2000) Effect of selenium in combination with adriamycin or taxol on several different cancer cells. Anticancer Res 20, 1391-1414.
12. Li J, Zuo L, Shen T, Xu CM & Zhang ZN (2003) Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitchondria. J Trace Elem Med Biol 17, 19-26.
13. Zhou N, Xiao H, Li TK, Nur-E-Kamal A & Liu LF (2003) DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem 278, 29532-29537.
14. Waters DJ, Shen S, Cooley DM, Bostwick DG, Qian J, Combs GF Jr, Glickman LJ, Oteham C, Schlitller D, Morris JS (2003) Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 95, 237-241.
15. Zhong W & Oberley TD (2001) Redox-mediated effects of selenium on apoptosis cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61, 7071-7078.
16. Ghose A, Fleming J, el-Bayoumy K & Harrison PR (2001) Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: Involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 61, 7479-7487.
17. Lu J, Kaeck M, Jiang C, Wilson AC & Thompson HJ (1994) Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 47, 1531-1535.
18. Wilson AC, Thompson HJ, Schedin PJ, Gibson NW & Ganther HE (1992) Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem Pharmacol 43, 1137-1141.
19. Jiang C, Wang Z, Ganther H & Lu J (2002) Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostrate cancer cells. Mol Cancer Ther 1, 1059-1066.
20. Burk RF, Norsworthy BK, Hill KE, Motley AK & Byrne DW (2006) Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 15, 804-810.
21. Thompson HJ, Wilson A, Lu J, Singh M, Jiang C, Upadhyaya P, el-Bayoumy K & Ip C (1994) Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15 183-186.
22. Reddy BS, Upadhaya P, Simi B & Rao CV (1994) Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis. Anticancer Res 14, 2509-2514.
23. Ip C & Ganther HE (1990) Activity of methylated forms of selenium in cancer prevention. Cancer Res 50, 1206-1211.
24. Behne D, Hilmert H, Schied S, Gessner H & Elger W (1988) Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochem Biophys Acta 966, 12-21.
25. 75Se labeling of specific proteins as a consequence of dietary selenium concentration in mice and rats. Proc Soc Exp Biol Med 196, 147-154.
26. Ganther HE (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis 20, 1657-1666.
27. Yang JG, Hill KE & Burk RF (1989) Dietary selenium intake controls rat plasma selenoprotein P concentration. J Nutr 119, 1010-1012.
28. Gallegos A, Berggren M, Gasdaska JR & Powis G (1997) Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57, 4965-4970.